We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

257:HKEXChina Everbright Environment Group Limited Analysis

Data as of 2026-03-14 - not real-time

HK$34.14

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading just above the twenty‑day moving average, which sits below the fifty‑day average, hinting at a slight downward bias. Momentum indicators are neutral, with the relative strength index hovering around the midpoint and the MACD line below its signal, signaling bearish momentum. Volume has been on a downtrend, and the recent price action is confined between a clear support zone and a higher resistance level, suggesting limited short‑term upside. The security shows elevated short‑term volatility and a beta above one, indicating higher price swings than the broader market.
Fundamental perspective: Revenue is growing at a healthy pace, yet margins remain thin and free cash flow is negative, while operating cash flow stays positive. The company carries a high debt load relative to equity and does not pay a dividend, reflecting a capital‑intensive business model. Valuation metrics show a forward price‑earnings multiple considerably lower than the trailing multiple, and analysts’ target prices imply a substantial upside from the current level. The business benefits from strong secular demand for battery materials, positioning it for long‑term growth despite the current financial constraints.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish MACD momentum
  • decreasing trading volume
  • price near short‑term support

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • robust revenue growth
  • improving forward earnings multiple
  • significant upside to analyst target price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • secular demand for EV and energy‑storage batteries
  • valuation gap relative to discounted cash‑flow estimate
  • potential for debt reduction as cash flows improve

Key Metrics & Analysis

Financial Health

Revenue Growth18.80%
Profit Margin2.90%
P/E Ratio21.6
ROE4.30%
ROA2.15%
Debt/Equity99.67
P/B Ratio1.3
Op. Cash FlowHK$3.3B
Free Cash FlowHK$-5770251776

Technical Analysis

TrendNeutral
RSI46.0
SupportHK$30.28
ResistanceHK$40.50
MA 20HK$35.47
MA 50HK$35.75
MA 200HK$33.07
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueHK$30.17
Target PriceHK$47.00
Upside/Downside37.67%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.16
Volatility73.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.